News
Press Releases
Brazil joins ANTICOV trial to find early treatments for people with mild-to-moderate COVID-19
RIO DE JANEIRO / GENEVA [Português] The ANTICOV study, a platform clinical trial which aims to find early treatments for mild-to-moderate cases of COVID-19 and is currently conducted in 13 African countries, is expanding
05 July, 2022Pfizer blocking research to generate evidence on optimal use of novel antiviral for COVID-19 patients in low- and middle-income countries
GENEVA / NEW YORK [Deutsch] [Français] The Drugs for Neglected Diseases initiative (DNDi), on behalf of a consortium of 26 African and global research organizations, expressed concern today that efforts to conduct urgent
15 March, 2022ANTICOV trial finds drug combination nitazoxanide + ciclesonide does not reduce risk of hospitalization in COVID-19 outpatients
KINSHASA / NAIROBI / GENEVA [Français] [Português] The ANTICOV platform clinical trial, launched in September 2020 in 13 African countries to identify treatments for mild and moderate cases of COVID-19, has stopped recru
28 February, 2022
ANTICOV: clinical trial for COVID-19 in low-resource settings to test a new combination treatment, fluoxetine and budesonide
KINSHASA / NAIROBI / GENEVA [Français] The ANTICOV platform clinical trial has started the recruitment of participants to test a new promising drug combination, fluoxetine and budesonide, as an early treatment for people
10 February, 2022
ANTICOV: largest clinical trial in Africa for people with mild COVID-19 to test new drug combination
[Français] The ANTICOV clinical trial, conducted in 13 African countries, has started the recruitment of participants to test a new drug combination, nitazoxanide + ciclesonide, to treat people with mild-to-moderate COVI
27 April, 2021
Largest clinical trial in Africa to treat COVID-19 cases before they become severe is launched in 13 countries
[Deutsch] [Español] [Français] [Português] [日本語] Thirteen African countries and an international network of research institutions have joined forces to launch the largest COVID-19 clinical trial in mild-to-moderate outpa
24 November, 2020
Stories
‘A clear demonstration of the capacity in Africa to conduct extremely complex studies’ – Dr John Amuasi on the ANTICOV trial in Ghana
Ghana is one of the 13 countries participating in the ANTICOV clinical study, whose goal is to identify treatments that could prevent mild-to moderate COVID. The internationally recognized biomedical research instit
30 July, 2021
Recruitment begins in Mozambique for ANTICOV clinical trial of early treatments for COVID-19
The availability of drugs to prevent mass hospitalisation is a priority for Africa This story was published by ISGlobal on 27 July 2021 and is available in English, Spanish, and Catalan. The two centres in Mozambiqu
29 July, 2021
Why Mali joined the ANTICOV clinical trial: A conversation with Dr Samba Sow
Early June, Mali enrolled its first patient in the ANTICOV clinical trial, a pan-African collaborative scientific study whose objective is to find treatments that can prevent mild-to-moderate COVID-19 cases fro
28 June, 2021
A few moments with an ANTICOV investigator: Dr Bernhards Ogutu in Kenya
On Friday 18 June, the first Kenyan patient was enrolled in the ANTICOV clinical trial. Kenya is the 5th country after the Republic of Guinea, the Democratic Republic of Congo, Mali and Ghana to start this large pan-Afri
18 June, 2021
Videos
Conducting life-saving research in a conflict zone: the ANTICOV study in Ethiopia
The ANTICOV clinical trial in Guinea
AVAREF and ANTICOV
Adaptive Platform Trials for Covid 19
This is research for Africans by Africans
Preparing for COVID-19 clinical trials in the DRC
Helpful links
Africa Center for Disease Control and Preparedness: https://africacdc.org/
COVID-19 Clinical Research Coalition: https://covid19crc.org/
World Health Organization Coronavirus (COVID-19) Dashboard: https://covid19.who.int/